Several decades after the discovery of selenium as an essential trace element in vertebrates approximately
Introduction: Some Historical Landmarks
The element selenium, discovered in 1817 and named after the Greek goddess of the moon by Berzelius, gained biomedical interest after Schwarz and Foltz (1957) reported that it is an essential trace element for mammals. The link between nutritional science and enzymology was, however, established appreciably later when Flohé et al. (1973) , intrigued by a preliminary report from Hoekstra's group (Rotruck et al., 1972) , identified selenium as a stoichiometric, covalently bound component of glutathione peroxidase (GPx) , an enzyme previously demonstrated to dominate mammalian hydroperoxide metabolism (Sies et al., 1972) . Selenium proved to be present in this enzyme as a selenocysteine residue (Forstrom et al., 1978 , Wendel et al., 1978 that is integrated into the amino acid chain (Günzler et al., 1984) . The selenocysteine residue in GPx is responsible for the catalytic efficiency, as demonstrated by site-directed mutagenesis (Rocher et al., 1992) , and the X-ray analysis performed by Epp et al. (1983) enabled a detailed understanding of the catalytic mechanism (Aumann et al., 1997 ; see also Figure 1A ).
Starting in the mid-eighties, further selenoproteins were discovered that broadened the scope of selenium biochemistry from antioxidant defense to multiple aspects of mammalian metabolism. The metabolic activation (Behne et al., 1990; Arthur et al., 1990; Davey et al., 1995) , as well as degradation of thyroid hormones (Croteau et al., 1995) , were shown to depend on selenium-containing deiodinases. Most surprisingly, selenium was also discovered in a well-documented enzyme of basic metabolic relevance, in thioredoxin reductase (Tamura and Stadtman, 1996) . Finally, a homolog of GPx, the phospholipid hydroperoxide glutathione peroxidase (PHGPx) originally described by Ursini et al. (1982) , proved to be involved in sperm maturation . Further surprises may be anticipated from the growing number of mammalian selenoproteins.
The selenium biochemistry of mammalian systems was paralleled, in fact often preceded, by related discoveries in prokarya. Already in 1954 selenium was rated as a growth factor of certain bacteria (Pinsent, 1954) . The first bacterial selenoproteins were described in 1973 (Andreesen and Ljungdahl, 1973; Turner and Stadtman 1973) , and the growing diversity of enzymatic functions of such prokaryotic enzymes remains a valuable guide to unraveling the roles of less accessible mammalian enzymes. The present understanding of selenoprotein biosynthesis could not have been achieved without the aid of microbial genetics. The key observation, though, was made with a mouse gene: it obviously encoded a mouse GPx and displayed the stop codon TGA precisely at the position that should encode selenocysteine in the homologous bovine enzyme (Chambers et al., 1986 ) that had been previously completely sequenced by protein chemistry (Günzler et al., 1984) . Within the same year Zinoni et al. (1986) established that TGA also encoded the selenocysteine discovered in bacterial formate dehydrogenase by Jones et al. (1979) . Starting from these observations, the complex biosynthesis of selenoproteins was unraveled for bacteria in a transatlantic cooperation that remains inseparably associated with the names of Stadtman and Böck (Zinoni et al., 1986; Böck and Stadtman, 1988; Böck et al., 1991a,b) . The attempts to understand eukaryotic selenoprotein biosynthesis has revealed homologies but also marked differences (Berry et al., 1991 (Berry et al., , 1993 , and has not yet yielded a satisfying comprehensive view.
Identified Selenoproteins
Selenium usually exerts its influence on physiology as an integral component of proteins, into which it is incorporated in the form of selenocysteine (Cone et al., 1976; see below) . Selenoproteins can be selectively labeled by 75 Se in selenium-deficient animals and autoradiographically visualized after electrophoretic separation (Behne et al., 1996) . According to such experiments, the number of selenoproteins in mammals has been estimated to reach 30 -50. Less than 20 of such bands have been characterized by sequence analysis up to now and an enzymatic function was assigned to more than ten of them. Among the identified and relatively well-characterized selenoproteins are four glutathione peroxidases (GPx), the cytosolic GPx (cGPx), the gastrointestinal GPx (GI-GPx), plasma GPx (pGPx) and phospholipid hydroperoxide GPx (PHGPx), at least three thioredoxin reductases (TrxR), three deiodinases (D), the selenophosphate synthetase-2, the selenoprotein P (SelP) present in plasma and a related variant in bovine brain (SelP12), the selenoprotein W in muscle, and some others of unknown function (Table 1 ).
In the majority of known mammalian selenoproteins, selenium occurs in the form of selenocysteine, which has proved to be essential for efficient catalysis Gromer et al., 1998; Köhrle, 2000b; Lee et al., 2000) . If selenocysteine is substituted by cysteine, the activity of the selenoenzymes falls by 2 to 3 orders of magnitude. Accordingly, the natural cysteine-containing PHGPx homolog from Plasmodium falciparum is approximately 1000-fold less active than 'true' Se-PHGPx (Sztajer et al., 2000) .
In prokarya, enzymes that were post-translationally modified with selenium were characterized. The carbon monoxide dehydrogenase, for instance, is an extremely complex molybdopterine-containing iron-sulphur-flavoprotein (Dobbek et al., 1999) , in which a selanyl group is bound to a cysteine residue ( Figure 1B ). Such selenoproteins have not yet been described in vertebrates. However, in prokarya the overwhelming number of selenoproteins contain selenocysteyl residues (Table 2) . They comprise selenoproteins that are present in eukarya as sulfur homologs like the peroxiredoxins (Rhee et al., 1999; Flohé et al., 1999) . Most prokaryotic selenoproteins, however, are unique and catalyze highly-varied processes that have not been discovered in eukarya. In the clostridial cluster XI (Kreimer and Andreesen, 1995; Wagner et al., 1999; Kabisch et al., 1999) , selenoproteins are vital for energy production, particularly under stress, and appear to be important for additional metabolic performances and pathogenicity. A better understanding of such unique pathways in clinically relevant microorganisms might provide a rational basis for therapeutic intervention.
Metabolic Function of Mammalian Selenoproteins
Glutathione peroxidases are found in all mammalian tissues in which oxidative processes occur. By reduction of hydroperoxides to the corresponding alcohols, these enzymes can prevent the production of reactive oxygen radicals and thus may contribute to the protection of the Selenium in Biology 851 Ursini et al., 1982; Brigelius-Flohé et al., 1994 Plasma GPx (pGPx, GPx-3) Takahashi et al., 1987 Gastrointestinal GPx (GI-GPx, GPx-GI, GPx-2) Chu et al., 1993 Iodothyronine deiodinases 5Ј-deiodinase, type I (5ЈDI) Behne et al., 1990; Arthur et al., 1990 5Ј-deiodinase Lee et al., 1999; Watabe et al., 1999; Miranda-Vizuete et al., 1999; Gasdaska et al., 1999 Thioredoxin reductase homologs (SelZf1; SelZf2) Lescure et al., 1999 Selenophosphate synthetase-2 Guimaraes et al., 1996 Functionally undefined 15 kDa selenoprotein of T cells Gladyshev et al., 1998 Selenoprotein P 10 (SelP) Motsenbocker and Tappel Lescure et al., 1999 Selenoprotein N (SelN) Lescure et al., 1999 organism's macromolecules and biomembranes against oxidation (Sies et al., 1972; Flohé, 1989; Ursini et al., 1995) . The role of the cytoplasmic GPx as an 'emergency enzyme' to fight oxidative stress was verified by reverse genetics (Ho et al., 1997; Cheng et al., 1998; de Haan et al., 1998; Fu et al., 1999; Jaeschke et al., 1999) and, in this role, cGPx cannot be substituted by any of the other selenoproteins. Glutathione peroxidases, in particular the less ubiquitously distributed isozymes, are engaged in redox regulation of many metabolic processes (BrigeliusFlohé, 1999 ) and appear to be involved in peroxinitrite scavenging (Sies et al., 1997) . PHGPx may, e. g., regulate the biosynthesis of leukotrienes, thromboxanes and prostaglandins and thus modulate inflammatory processes (Smith and Lands, 1972; Haurand and Flohé, 1988; Schnurr et al., 1996; Weitzel and Wendel, 1993; Imai et al., 1998) . Glutathione peroxidases, in particular PHGPx, have further been shown to dampen cytokine-induced transcriptional gene activation , e. g. by inhibiting phosphorylation of IB (KretzRemy et al., 1996) . All of the three deiodinase isoenzymes identified up to now appear to contain selenocysteine (Figure 2 ). These enzymes catalyze the activation of the prohormone thyroxine (T4), which is secreted by the thyroid, to the active thyroid hormone 3,3Ј,5-triiodothyronine (T3) (type I and type II 5Ј-deiodinase) or the deiodination of T4 and T3 to metabolites (type III 5-deiodinase) that are not hormonally active. These three isozymes are encoded by different genes and show distinct specificities, tissue-and development-specific expression patterns and regulation. Essentially they control the local availability and concentration of the highly active thyroid hormone T3 (reviewed in Köhrle, 1999a Köhrle, , b, 2000a .
In contrast to prokaryotic homologs, thioredoxin reductase of mammals was identified as a selenoprotein (Tamura and Stadtman, 1996) . It needs selenocysteine as the penultimate amino acid residue for its appropriate enzymatic function (Marcocci et al., 1997; Gromer et al., 1998; Lee et al., 2000; Gorlatov and Stadtman, 2000) . Recently, two more tissue-specifically expressed isoenzymes were also identified as selenoproteins (Gasdaska et al., 1999; Lee et al., 1999; Watabe et al., 1999) and related proteins were identified by 'in silico' cloning (Lescure et al., 1999) . Various natural and synthetic compounds, apart from disulfide groups in peptides and proteins, can be reduced by TrxR Björnstedt et al., 1995) . The natural substrate of TrxR, thioredoxin (Trx), is a central regulator of the cellular redox status (Follmann and Häberlein, 1995) . It is, e. g., required for the redox-regulated function of transcription factors and hormonally-regulated nuclear receptors. Furthermore, ribonucleotide reductase needs reduced Trx for the production of deoxynucleotides. Thus, TrxR enables a basic metabolic process and regulates multiple metabolic events in eukaryotic cells (Hayashi et al., 1993; Björnstedt et al., 1997; Makino et al., 1999; Holmgren, 2000) . Likely, it is the pivotal role of selenium in TrxR that explains why a knock-out of the seleno- cysteyl-tRNA gene is lethal in mice (Bösl et al., 1997) , since targeted disruption of the thioredoxin gene proved to be equally lethal (Matsui et al., 1996) . Approximately 60 -70% of the plasma selenium is bound in the selenoprotein P. The function of this protein is not yet clear. It is assumed to be an extracellular antioxidative protein which contributes to the decomposition of peroxinitrite (Arteel et al., 1998; or might exhibit some in vitro peroxidase activity (Sies et al., 1999) like many natural and synthetic selenocysteine-containing proteins (Haring and Schreier, 1999) . However, it could equally well bind heavy metals (Burk and Hill, 1994) . The role of the selenoprotein P as a transport protein of selenium in plasma has meanwhile been questioned, because selenocysteine could only be released by destroying the protein (Burk and Hill, 1994) . Selenoprotein P is presumed to exert its antioxidative effect particularly in the vascular system, where it is bound to endothelial cells with high affinity (Hill and Burk, 1997) , probably via its histidine-rich domains as shown by in vitro interaction with heparin (Arteel et al., 2000) . The inhibition of the activity of the human selenoprotein P promoter and the protein expression through pro-inflammatory cytokines and TGF␤ in liver cells characterizes selenoprotein P as a negative acute phase protein (Dreher et al., 1997 , Mostert et al., 1999 .
Recently, selenoprotein P has further been reported to promote neuron survival in vitro (Yan and Barrett, 1998) .
The Biosynthesis of Selenoproteins
The biosynthesis of selenoproteins in prokaryotes has been largely clarified (Böck, 2000;  Figure 3 ). Related studies were mainly conducted with formate dehydrogenase in E. coli, which also contains selenium as a selenocysteine residue integrated in the peptide chain. The insertion of the selenocysteine is encoded by the triplet TGA, which usually functions as a stop codon (Zinoni et al., 1986; Böck and Stadtman, 1988; Böck et al., 1991a) . Recoding of TGA as a selenocysteine codon requires an mRNA secondary structure called SECIS (for selenocysteine-insertion sequence), which, in bacteria, is localized immediately downstream of the UGA codon. This secondary structure is recognized by a special translation factor, SelB (Baron et al., 1993) , which directs a special tRNA (Ser)Sec , encoded by the SelC gene, to the ribosome, where the latter enables the incorporation of selenocysteine by means of a UGA anticodon (Leinfelder et al., 1988; Forchhammer et al., 1991) . The selenocystyl-loaded tRNA (Ser)Sec is synthesized from a seryl-loaded tRNA Figure 2 illustrates the conformational aspects of thyroid hormones and the bulky iodine atoms (black) of the non-planar diphenylether aromatic ring system (modified from Cody et al., 1986) . Whereas T4 and T3 occupy a skewed conformation, the inactive metabolite rT3, lacking the iodine atom in the 5-position, has an antiskewed orientation of the two phenolic rings. The physiological cofactor(s) of these deiodinase selenoenzymes is (are) unknown.
Iodine Nitrogen Oxygen
Carbog Hydrogen phate (Leinfelder et al., 1990) , which is generated from H 2 Se and ATP (Lacourciere, 1999; Lacourciere and Stadtman, 1999) . The eukaryotic system of selenoprotein synthesis appears to be homologous in part (Figure 3) . The selenocysteine codon is TGA (UGA) again; the tRNA (Ser)Sec (Lee et al., 1989 ) and the selenophosphate synthetase (Low et al., 1995; Guimaraes et al., 1996; Lacourciere and Stadtman, 1999) are closely related. The essential difference of the eukaryotic selenocysteine biosynthesis system consists in the position of the SECIS element. In eukarya, it is located in the 3Ј nontranslated region and thus decoding from an appreciable distance is necessary (Berry et al., 1993; Low and Berry, 1996) . In this respect the archaeal selenoprotein biosynthesis is more similar to the eukaryotic system than to the bacterial system (Wilting et al., 1997) . Considering the similarity of the systems, a SelB-orthologous translation factor is also postulated for eukarya, which should have affinity to both SECIS and tRNA sec , and should control the correct decoding of the distant UGA codon by competing with the termination factor (Nasim et al., 2000) . Up to now, the eukaryotic SelBortholog could not yet be identified. Using gel shift experiments, various proteins that bind to eukaryotic SECIS structures were detected. The bands, however, differ in molecular masses (from 48 -120 kDa) and their affinities to SECIS elements of a given selenoprotein mRNA could usually not be compared to that of other SECIS elements (Shen et al., 1995 (Shen et al., , 1998 Yamada, 1995; Hubert et al., 1996; Lesoon et al., 1997) . A protein of 120 kDa was reported to be required for eukaryotic selenoprotein biosynthesis (Copeland et al., 2000 , as well as selenocysteine incorporation, might be exerted by two (or more) different proteins in archeae and mammalia (Rother et al., 2000) .
Regulation of Selenoprotein Expression

Tissue-Specific Expression
The more common selenoproteins display an expression pattern that reflects the metabolic activity of the tissue, whereas others are more selectively distributed.
Type I 5Ј-deiodinase is found primarily in thyroid, liver, kidney and pituitary, type II 5Ј-deiodinase in brown fat tissue of rodents, in placenta, thyroid, pituitary, and in the central nervous system, type III 5-deiodinase in skin, placenta and also in the central nervous system (Köhrle, 2000b) . The testicle is the tissue containing the highest amount of PHGPx (Maiorino et al., 1998) . In Schistosoma mansoni, PHGPx is found in the female genitals (Maiorino et al., 1996) . GI-GPx is expressed only in the gastrointestinal tract (Chu et al., 1993 , Mörk et al., 1998 Wingler and Brigelius-Flohé, 2000) , whereas pGPx is secreted and preferentially formed at metabolic surfaces (proximal tubulus of the kidney, intestinal epithelium, skin, lung, epididymis, vas deferens, chorioidal plexus; Brigelius- Flohé, 1999) . The extracellular selenoprotein P displays a similar expression pattern but is highly expressed in liver and, surprisingly, also in testicular Leydig cells and the Purkinje layer of the cerebellum . Among the selenoproteins, which are not yet defined functionally or structurally, selenoprotein W is found in heart and skeletal muscle, other poorly characterized selenoproteins in testis, prostate and pancreas (Behne et al., 1997) . Decoding of the UGA codon as selenocysteine and its subsequent incorporation requires a complex multicomponent system and several reactions. These include: (A) the formation of the selenium donor, selenophosphate, from ATP and selenide, catalyzed by the selenophosphate synthetase-2 (SELD), which is a selenoenzyme by itself; (B) a specific tRNA, called tRNA (Ser)Sec or SelC, which is first loaded with serine and then converted into selenocysteine (Sec) by selenocysteine synthase (SELA) using selenophosphate as selenium source; (C) a putative translation complex in analogy to the established complex in prokarya. The mRNA forms a characteristic secondary structure in the 3' nontranslated region, the selenocysteine incorporating sequence (SECIS). The selenocysteine-loaded tRNA (Ser)Sec is transferred to the ribosome A site and recognizes the UGA codon by its anticodon ACU. The complex is stabilized via the interaction of putative SECIS-binding proteins ('SelB') with the SECIS and the tRNA. These components of the translational complex remain to be identified.
The sometimes unusual expression pattern certainly points to highly-specialized roles. In none of the cases has the molecular basis for tissue-specific expression so far been elucidated and, apart from PHGPx and the deiodinases (see below), the tissue-specific biological role of the selenoproteins remains obscure.
Hormone-Dependent Regulation
In fetal osteoblast-like cells (hFOB), human thioredoxin reductase is rapidly induced, like an immediate-early gene, through 1,25-dihydroxy vitamin D3, certain cytokines and growth factors; here also the selenium status modulates the expression of TrxR (Schütze et al., 1998a, b) . The three deiodinase isoenzymes are regulated by thyroid hormones, retinoids, sexual hormones, gluco-and corticosteroids and a series of growth factors and cytokines, as verified by promoter studies for individual deiodinase isoenzymes Schmutzler et al., 1998 , for an overview see Köhrle, 2000b) .
Hormone-dependent expression of PHGPx, which had been assumed to be mediated by putative hormoneresponsive elements in the promoter or in the introns (Brigelius-Flohé et al., 1994) , could not be verified by reporter gene constructs. PHGPx rather is preferentially expressed in round spermatids. These cell's development in turn depends on testosterone (Maiorino et al., 1998) . The androgen-dependent expression of pGPx in epididymis might be based on the same principle of hormone-mediated growth and differentiation of the producing cell type (Schwaab et al., 1998) .
Regulation by Oxidative Stress
An induction of GPx genes by oxidative stress was often postulated but has never been convincingly demonstrated in vivo. The induction of cGPx through an oxygen-responsive element has only been described in vitro (Cowan et al., 1993 ; for a review see Flohé et al., 1997) .
Selenium-Dependent Regulation
Biosynthesis of selenoproteins, of course, depends on the bioavailable selenium. Their biosynthesis, however, follows a strict hierarchy in the case of limited selenium supply (Burk and Hill, 1993; Sunde, 1994; Gross et al., 1995; Flohé et al., 1997) . Even within the family of glutathione peroxidases there are enormous differences in the expression in response to selenium (Brigelius-Flohé, 1999) . In all examined cases the PHGPx activity in selenium deficiency was stable for a long time, whereas the activity of cGPx declined quickly and substantially (Lei et al., 1995) . This loss of activity upon selenium deprivation is not only caused by reduced protein synthesis, but also by enhanced degradation of the pertinent mRNA. The mRNA stability of the cGPx is the lowest, that of the PHGPx is relatively unchanged and reduced only under severe selenium deficiency. That of GI-GPx is extremely high. The mRNA even increases under poor selenium provision (Wingler et al., 1999) . The reasons for this phenomenon are not clear at all. It is likely that the mRNA stability is regulated by selenium-responsive RNA-binding proteins in an analogous way as has been demonstrated for mRNA of proteins involved in iron metabolism (Hentze, 1991) . It has not yet been examined in detail whether mRNA stability responds to selenium in a tissue-specific manner.
Medical Implications
The characteristics of selenium deficiency, but also of selenium toxicity, are largely known from epidemiological studies. At present, a daily intake of 70 g for adults is considered normal, while daily intakes below 20 g are rated as insufficient. The toxicity limit is estimated at 800 g per day (Bähr et al., 1999) .
Comprehensive analyses of selenium deficiency in livestock production and agriculture were conducted in the US, New Zealand and other regions with varying selenium supply, as reviewed extensively by the National Research Council (1983) of the United States. As a consequence, selenium supplementation of animal food or the use of mineral fertilizers has become routine in many seleniumdeficient countries, although the basic biochemical processes causing the deficiency symptoms remain to be worked out. Human selenium supply relies on such animal-mediated enrichment of the food chain in many regions of the world, where selenium, like iodine, has been eluted from agriculturally-used soils and earth surfaces and is no longer supplied to the food chain via assimilation by plants.
Manifest Selenium Deficiency
While typical selenium deficiency syndromes of livestock, like white muscle disease in cattle, mulberry heart disease in pig, and exsudative diathesis in poultry, have been recognized in many countries, manifest selenium deficiency is commonly not a problem for humans living in developed countries, where people have access to varied food derived from diverse sources. Human diseases unambiguously attributed to, or associated with, selenium deficiency have been reported to occur only in remote rural areas with extreme selenium deficiency.
In a cooperation between Chinese and American groups, the pathophysiology of the exemplary Chinese selenium deficiency syndrome, Keshan disease, was largely clarified: against the background of a selenium deficiency, coxsackie viruses become virulent. This etiology of Keshan disease has recently been corroborated by compelling animal experiments. In both selenium-deficient and cGPx(-/-) mice, avirulent Coxsackie strains mutated into virulent ones (Beck et al., 1998) . Selenium deficiency, thus, is a necessary but not a sufficient condition to cause disease manifestation.
Detailed concepts for the pathogenesis of the myxoedematous cretinism have been developed from epidemiological and intervention studies by Dumont's team in Brussels in cooperation with Central African and Asian teams. The resulting hypotheses are now being tested in animal experiments. This disease occurs in the case of a serious simultaneous selenium and iodine deficiency, whereas iodine deficiency alone leads to a neurological type of cretinism (Dumont et al., 1994; Köhrle 1999a) . Whether the Kashin Beck osteoarthropathy is also caused by selenium deficiency or combined selenium and iodine deficiency is still the topic of scientific controversy. In any event, further pathogenic factors, e. g. mycotoxins, appear to contribute to this peculiar syndrome (Ge and Young, 1993; Moreno-Reyes et al., 1998) .
Selenium and Tumor Incidence
The relationship between selenium supply and cancer incidence is supported by epidemiological surveys, and cohort and case control studies, as well as by retrospective and prospective prevention or intervention studies (National Research Council, 1983) . Different approaches from several regions (e. g. China, USA, Scandinavia) almost unanimously demonstrated low selenium intake to be associated with a higher incidence of mammary, thyroid, prostate, lung and colorectal carcinoma (for recent overviews see Combs et al., 1997; Combs and Gray, 1998; Knekt et al., 1998) . Animal experiments on initiation, promotion and proliferation of tumors tended to support a beneficial effect of selenium. In animal experiments, however, individual selenium compounds differed in their efficacy (Ip and Ganther, 1990; Ip, 1998) . The protective effect of selenium is not readily explained in terms of prevention of oxidative DNA damage, since, as a rule, higher dosages of selenium than those optimizing peroxide metabolism are required (Combs et al., 1997; Combs and Gray, 1998; Ganther, 1999) . Accordingly, topical discussions presume a direct antiproliferative effect of pharmacological selenium concentrations, be it due to enhancement of apoptosis by excess selenium supply or to distinct inhibition of proliferation-enabling enzymatic processes by certain selenium metabolites (Ganther, 1999) .
A pivotal prospective, placebo-controlled, doubleblind study conducted with more than 11 00 patients over 4.5 years on average and a selenium supplementation of 200 g/d in the form of selenium-enriched yeast remained ambiguous in failing the main endpoint, i. e. lowering the recurrence of non-melanoma skin cancer, but surprised in meeting secondary endpoints beyond expectations: total cancer incidence and cancer mortality were significantly lowered by supplementation. Particularly the incidence of colorectal, pancreatic and lung tumors decreased during the intervention and the 6.5-year follow up-period in the selenium-supplemented group (Clark et al., 1996) . To comply with biometric rules, however, the observations have to be verified in dedicated examinations.
Selenium and Intensive Care Medicine
Critically ill patients, above all those with systemic inflammatory response syndrome (SIRS), have lower serum selenium levels and GPx activity already when they are admitted to intensive care units (Hawker et al., 1990; Gärtner et al., 1997) . In SIRS patients, the abundant H 2 O 2 formation necessitates adequate protection by glutathione peroxidases (Prabha et al., 1991) . Low serum selenium levels correlate with the low GPx activity and are almost consistently found during the hyperdynamic septic phase of shock, after surgery, or in patients with liver diseases (Robinson et al., 1992) . Also, serum selenium levels correlate inversely with mortality (Forceville et al., 1998) . The reason is still not clear. Selenium-deficient nutrition is discussed as a predisposing factor for SIRS (Richard et al., 1991; Ringstad et al., 1993) . But also a rapid redistribution of selenium in the body or an excretion through the kidney at the beginning of the disease has been supposed, but could not yet be analytically verified (Forceville et al., 1998) . During longer parenteral nutrition and continuation of the disease the selenium level further decreases (Hawker et al., 1990; Sando et al., 1992) . It is equally unclear how a selenium supplementation might interfere with the septic syndrome. Normalization of peroxide metabolism is most frequently discussed. But a mechanistically unclear improvement of the immune response that is observed upon selenium supplementation (McKenzie et al., 1998) , comprising inter alia enhanced activity of natural killer cells (Dimitrov et al., 1986) , might be of particular relevance in the late phases of SIRS.
First pilot studies have addressed the effect of selenium on septic diseases with promising results (Gärtner et al., 1997; Zimmermann et al., 1997; Angstwurm et al., 1999) . In these conditions, the usual parenteral nutrition, which contains low dosages of selenium (35 g/day), neither leads to a normalization of serum selenium levels nor to an increase of GPx activity. Based on the preliminary data, controlled prospective studies examining the efficiency of selenium at different dosages in an adequate number of patients appear mandatory, because SIRS still has one of the highest mortality rates (40% on average) among the acute diseases.
Selenium and Thyroid Function
The human thyroid contains a high amount of selenium because it produces H 2 O 2 for oxidative thyroid hormone synthesis and has to protect itself from oxidative damage by the expression of selenoperoxidases. Moreover, it needs selenium for activating the prohormones of T4 to T3 catalyzed through the 5Ј-deiodinases. As mentioned above, serious selenium deficiency combined with iodine deficiency leads to a myxedematous type of cretinism. In iodine deficiency, the production of H 2 O 2 is stimulated by pituitary thyrotropin (Dumont et al., 1994) . In this condition, the thyroid is postnatally damaged and becomes fibrotic under the influence of TGF␤ (Contempre et al., 1996) . But there are also hints that the selenium status influences the progress of auto-immune diseases of the thyroid (1/6 of all women have thyroid auto-antibodies) by unclear mechanisms (Schmidt et al., 1998; Köhrle, 1999a) . Also, lower selenium concentrations can be found in thyroid tumor tissue (Köhrle, 1999a) . In a large-scale Norwegian study, a significantly higher incidence of thyroid tumors correlated with prediagnostical low selenium levels (Glattre et al., 1989) . The role of the individual selenoproteins in pathologically altered thyroid tissue is, however, as unclear as their contribution to auto-immune diseases and tumor development. Neither is it evident whether there is a direct link between the low selenium status in critically ill patients (e. g. SIRS) and the simultaneously observed low T3-production due to inefficiently expressed hepatic selenoprotein type I 5Ј deiodinase in the 'Low-T3-Syndrome' (Köhrle et al., 2000b) .
Selenium and Male Fertility
The necessity of adequate selenium provision for male fertility is known particularly from veterinary medicine (see National Research Council, 1983, and Flohé, 1989 for older literature) . Yet the precise role of selenium in male fertility remained an enigma for decades. In sperm, selenium is largely associated with the keratin-like material that embeds the helix of mitochondria in the midpiece of spermatozoa. A protein derived from this so-called mitochondrial capsule was reported to contain selenium and accordingly termed 'mitochondrial capsule selenoprotein (MCS)' (Pallini and Bacci 1979; Calvin et al., 1981) . The pertinent genes of rats and mice, however, did not contain any TGA codons within the translated regions (Adham et al., 1996; Cataldo et al., 1996) . Accordingly, MCS could no longer be considered the selenoprotein essential to sperm function. More recent studies showed that PHGPx is abundantly expressed in spermatogenic cells (Maiorino et al., 1998 Mizuno et al., 2000) but exists as an enzymatically-inactive structural protein in mature sperm, where it contributes to the formation of the mitochondrial capsule . In spermatozoa, PHGPx thus replaces MCS, which had mistakenly been considered a selenoprotein. Because the morphological defects of sperm under selenium deficiency primarily affect the mitochondrial capsule, reduced fertility can conceivably be explained by insufficient PHGPx synthesis. The relevance of further selenoproteins that are specifically expressed in the male genitalia (Behne et al., 1997 ) has yet to be clarified.
Selenium and Atherogenesis
Fatty acid and cholesterol ester hydroperoxides, as present in oxidized LDL (oxLDL), are believed to initiate atherogenesis (Steinberg, 1997) . In atherosclerotic lesions, hydroperoxides as well as the 15-lipoxygenase were found (Ylä-Herttuala, 1991) , and lipid hydroperoxides can induce adhesion molecules in cultivated endothelium cells (Friedrichs et al., 1999) . Both oxLDL-induced foam cell formation and smooth muscle cell proliferation and hydroperoxide-induced presentation of adhesion molecules are considered to synergize in the initiation of atherogenesis.
A prophylactic role of selenium in the prevention of cardiovascular disturbances was observed in epidemiological studies (National Research Council, 1983; Salonen, 1987) . In view of the oxidative processes implicated in early atherogenesis, the selenium effect is tentatively attributed to the optimization of glutathione peroxidase activities. Possible candidates would particularly be the pGPx as an extracellular enzyme and PHGPx, which efficiently reduces hydroperoxides in oxidized LDL. This seemingly straightforward hypothesis, however, suffers from at least two inconsistencies: pGPx lacks a sufficient supply of reducing capacity in the extracellular compartment (Brigelius-Flohé, 1999 ) and does not have the optimum specificity (Yamamoto and Takahashi, 1993) , PHGPx does display the optimum specificity to reduce all kinds of hydroperoxy groups in oxLDL (Ursini et al., 1982 but is not present extracellularly, where LDL is oxidized, and does not readily decline in moderate selenium deficiency. Clearly, the link between selenium and atherogenesis, if real, has still to be identified. It is likely that the redox regulation of lipid mediator synthesis and cytokine-dependent signaling is more relevant to the initiation of atherogenesis than the mere antioxidant potential of selenoperoxidases (Brigelius-Flohé, 1999) .
Conclusions
The exponential progress in selenium biochemistry over the last two decades led to the identification, cloning and functional characterization of more than a dozen selenoenzymes with widely varied catalytic potential, and the key events of selenoprotein biosynthesis have been elucidated. This review is, however, not primarily meant to celebrate these achievements, it rather aims at underscoring that most of the roles of the essential trace element in biology still remain as obscure as they have been for most of the last century. This is because the trace element typically hides in 'trace enzymes'. In fact, the present state of the art could not have been achieved without advanced molecular biology techniques and most sophisticated physicochemistry.
For a long time, the selenium biochemistry was misinterpreted as the search for biological curiosities that might detract serious scientists from central biological problems. This view can no longer be maintained: as an integral moiety of the thioredoxin reductases it is relevant to basic steps of nucleic acid synthesis; it proved to be essential for male fertility in mammals; and the knock-out of the selenocystyl-tRNA gene in mice was lethal (Bösl et al., 1997) and thus revealed that at least one of the selenoproteins must be indispensable for mammalian life in general.
Most of the known selenoproteins were detected in either bacteria and archaea or in mammals, but selenoproteins are definitely also present in lower eukarya (Maiorino et al., 1996) . Little is known about the role of selenium in the remaining living kingdom. Plants appear not to depend on selenoenzymes, yet they contain numerous low molecular weight selenocompounds of nutritional, pharmacological, and toxicological interest (Läuchli, 1993; Neuhierl et al., 1999) . Together with bacteria, which may also 'dissimilate' bioavailable selenite to elementary selenium (Garbisu et al., 1995) , plants, by assimilation of inorganic selenium, certainly contribute to the maintenance of the geo-ecological selenium homeostasis that is equally important for livestock and human health (National Research Council, 1983) .
As a rule the catalytic potential of known bacterial selenoenzymes is not paralleled by mammalian selenoproteins and vice versa, selenophosphate synthetase being the only known exception. Our fragmentary knowledge does not, however, exclude the possibility that the highly complex catalytic centers comprising selenocysteine, pterine cofactor-bound molybdenum and flavin or selenocysteine-coordinated iron/nickel/sulfur clusters are not used in eukaryotes. New sequences of mammalian selenoproteins are being detected at high speed by 'in silico cloning' (Lescure et al., 1999; Kryukov et al., 1999) , and pulse-label experiments with radioactive selenium suggest the existence of another dozen or two, giving ample room for further surprises when the catalytic potentials and structures of these proteins emerge. It can also not be taken for granted that selenium exerts its catalytic role in mammals exclusively as a selenocysteine residue that is integrated into proteins. The chemical nature of the 'acidvolatile selenium' (Diplock et al., 1973) of rat liver has never been worked out. Certainly, H 2 Se eventually could be generated from acid-denatured selenocysteine-containing proteins by ␤-elimination, but liberation of H 2 Se by acid from a selanyl-bond, as present in bacterial CO dehydrogenase, or from iron/selenide clusters, must be rated as more likely.
As to the medical implications of selenium research, we may safely state that severe selenium deficiency requires supplementation, as is suggested from the eradication of Keshan disease in supplemented areas in China and the prevention of analogous symptoms in patients on supplemented parenteral nutrition. As evident from the experiments with cGPx(-/-) mice, the cardiac complication in selenium deficiency likely results from a disturbed hydroperoxide metabolism. Evidence is also emerging that selenium deficiency specifically complicates iodine deficiency by increasing the oxidative challenge to the thyroid. In all other pathological conditions for which selenium supplementation is currently discussed, neither a satisfying rationale nor compelling clinical data are available. Nevertheless, the beneficial effects of selenium inferred from softer data, e. g. epidemiological surveys on cancer incidence and cardiovascular disease, small-scale clinical trials with critically ill patients, the unexpected accidental observations in large-scale cancer prevention trials, or veterinary experience with selenium responsiveness of inflammatory diseases, should not be ignored. They certainly demand validation by dedicated prospective studies. In chronically developing multifactorial diseases like oncogenesis and cardiovascular disease such trials are hard to design, if they are feasible at all. Rather, these problems may be rationally approached by studying the potential relevance of individual selenoproteins and their dependency on the selenium status. Thereby, selenium-responsive disease-related surrogate endpoints could be defined, which then may be tested in short-term clinical trials with manageable sample sizes.
